Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7559
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:サウジアラビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group, is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products. The company offers products in various therapeutic areas including alimentary tract and metabolism, antineoplastic and immuno-modulators, blood and blood forming organs, cardiovascular system, systemic anti infective, dermatologicals, genito-urinary system and sex hormones, multivitamin, musculo skeletal, nervous system, parasitology and respiratory system, among others. It markets its products in Saudi Arabia and abroad. Tabuk is headquartered in Riyadh, Saudi Arabia.

Tabuk Pharmaceuticals Manufacturing Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tabuk Pharma Enters into Distribution Agreement with Renapharma 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 11
Licensing Agreements 12
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 12
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 13
Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 14
Tabuk Pharma Enters into Licensing Agreement with Aenova 15
Tabuk Pharma Enters into Licensing Agreement with Pfizer 16
Asset Transactions 17
Acino Pharma Acquires Three Products from Tabuk Pharma 17
Tabuk Pharmaceuticals Manufacturing Company – Key Competitors 18
Tabuk Pharmaceuticals Manufacturing Company – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Key Facts 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Deals By Therapy Area, 2012 to YTD 2018 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tabuk Pharma Enters into Distribution Agreement with Renapharma 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 11
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 12
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 13
Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 14
Tabuk Pharma Enters into Licensing Agreement with Aenova 15
Tabuk Pharma Enters into Licensing Agreement with Pfizer 16
Acino Pharma Acquires Three Products from Tabuk Pharma 17
Tabuk Pharmaceuticals Manufacturing Company, Key Competitors 18
Tabuk Pharmaceuticals Manufacturing Company, Other Locations 18

List of Figures
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mymetics Corp (MYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respi …
  • Altin Yunus Cesme Turistik Tesisler A.S.:企業の戦略・SWOT・財務分析
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Shire Plc (SHP)-医療機器分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • IAC/INTERACTIVECORP:企業の戦略・SWOT・財務分析
    IAC/INTERACTIVECORP - Strategy, SWOT and Corporate Finance Report Summary IAC/INTERACTIVECORP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Alviva Holdings Ltd (AVV):企業の財務・戦略的SWOT分析
    Alviva Holdings Ltd (AVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lightbridge Corporation (LTBR)-エネルギー分野:企業M&A・提携分析
    Summary Lightbridge Corporation (Lightbridge) is a nuclear fuel technology company, which develops thorium based nuclear fuel technologies for nuclear reactor systems, that increases the power output of commercial reactors; generates nuclear energy and the amount of nuclear waste on a per-megawatt-h …
  • Vedanta Ltd:企業のM&A・事業提携・投資動向
    Vedanta Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • Stealth BioTherapeutics Corp (MITO):企業の戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Vascutek Ltd:製品パイプライン分析
    Summary Vascutek Ltd (Vascutek), a subsidiary of Terumo Corp is a medical equipment company that designs, manufactures and distributes vascular and cardiovascular products. The company provides products such as stent graft system, aortic root designs, polyester products and EPTFE products, among oth …
  • Eurobank Ergasias SA:企業のM&A・事業提携・投資動向
    Eurobank Ergasias SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurobank Ergasias SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Venoco, LLC-石油・ガス分野:企業M&A・提携分析
    Summary Venoco, LLC (Venoco), formerly known as Venoco, Inc., is an independent energy company. It carries out acquisition, exploration, exploitation and development of oil and natural gas properties. The company’s major onshore and offshore properties are located in Southern California. Venoco offs …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Operation Technology Inc:企業の戦略的SWOT分析
    Operation Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Devon Energy Corp (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its op …
  • IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • Orange Belgium (OBEL):企業の戦略的SWOT分析
    Orange Belgium (OBEL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Valero Energy Corporation:企業の戦略・SWOT・財務情報
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆